{"id":48473,"date":"2026-07-31T01:57:00","date_gmt":"2026-07-30T23:57:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=094b507e708c7039ef425763e5b2dd02"},"modified":"2026-07-31T01:57:00","modified_gmt":"2026-07-30T23:57:00","slug":"alnylam-pharmaceuticals-inc-alny-shareholders-who-lost-money-contact-law-offices-of-howard-g-smith-about-securities-fraud-investigation","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=48473","title":{"rendered":"Alnylam Pharmaceuticals, Inc. (ALNY) Shareholders Who Lost Money \u2013 Contact Law Offices of Howard G. Smith About Securities Fraud Investigation"},"content":{"rendered":"

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Alnylam Pharmaceuticals, Inc. (\u201cAlnylam\u201d or the \u201cCompany\u201d) (NASDAQ: ALNY<\/a>) investors concerning the Company\u2019s possible violations of federal securities laws.<\/p>

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ALNYLAM PHARMACEUTICALS, INC. (ALNY), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.<\/b><\/p>

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com<\/a>, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com<\/a>.<\/p>

What Happened?<\/b><\/p>

On July 30, 2026, Alnylam announced second quarter 2026 financial results. Among other things, the Company reported it has \u201clowered our TTR product sales guidance<\/b><\/i> for full-year 2026 to reflect learnings from the initial phase of our launch in the evolving ATTR-CM market, in particular the normalization of growth in second line volume after satisfying pent-up demand from patients waiting for a new therapy<\/b><\/i>.\u201d As a result, the Company lowered its total projected TTR net product revenues by approximately $200 million.<\/b><\/i><\/p>

On this news, shares of Alnylam fell as much as $81.25 or 28.35% in intraday trading on July 30, 2026, thereby injuring investors.<\/p>

Contact Us To Participate or Learn More:<\/b><\/p>

If you purchased Alnylam securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:Law Offices of Howard G. Smith3070 Bristol Pike, Suite 112Bensalem, Pennsylvania 19020Telephone: (215) 638-4847Email: howardsmith@howardsmithlaw.com<\/a>Visit our website at: www.howardsmithlaw.com<\/a>.<\/p>

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

Law Offices of Howard G. SmithHoward G. Smith, Esquire215-638-4847howardsmith@howardsmithlaw.com<\/a>www.howardsmithlaw.com<\/a>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces an investigation on behalf of Alnylam Pharmaceuticals, Inc. (\u201cAlnylam\u201d or the \u201cCompany\u201d) (NASDAQ: ALNY) investors concerning the Company\u2019s possible violations of federal securitie…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-48473","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/48473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48473"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/48473\/revisions"}],"predecessor-version":[{"id":48474,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/48473\/revisions\/48474"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}